31 Dengue virus (DENV) is the most prevalent mosquito-borne virus in the world and a major cause 32 of morbidity in the tropics and subtropics. Upregulation of HLA class I molecules has long been 33 considered a feature of DENV infection, yet this has not been evaluated in the setting of natural 34 infection. Natural killer (NK) cells, an innate immune cell subset critical for mounting an early 35 response to viral infection, are inhibited by self HLA class I, suggesting that upregulation of 36 HLA class I during DENV infection could dampen the NK cell response. Here we addressed 37 whether upregulation of HLA class I molecules occurs during in vivo DENV infection and, if so, 38
whether this suppresses the NK cell response. We found that HLA class I expression was indeed 39 upregulated during acute DENV infection across multiple cell lineages in vivo. hemorrhage, plasma leakage, shock, organ failure, and death (Kyle and Harris, 2008) . The 55
incidence of dengue is rapidly rising (Organization and Others, 2012) , increasing the need for a 56 better understanding of how the human immune system responds to DENV infection. There is 57 significant interest in elucidating the role of natural killer (NK) cells during DENV infection. NK 58 cells are innate lymphoid cells that play a key role during the early stages of viral infection. 59
Previous studies have shown that NK cells are activated in vivo during DENV infection 60 (Azeredo, 2006; Petitdemange et al., 2016) and that activated NK cells may be an indicator of a 61 positive prognosis (Azeredo, 2006) . NK cell activation in response to virally infected cells is 62 dependent on the balance of activating and inhibitory signals from numerous germline-encoded 63 receptors. One such activating receptor, FcRγIIIa (CD16a), mediates antibody-dependent cell 64 cytotoxicity (ADCC), a key bridge between the adaptive and innate immune systems in which 65 antibodies bound to infected cells target them for NK cell killing (Laoprasopwattana et al., 2007; 66 Sun et al., 2017 66 Sun et al., , 2019 . NK cells can also kill DENV-infected cells in the absence of ADCC 67 (Costa et al., 2017) . Several NK cell receptors, namely DNAM-1, NKG2D, and NKp44 have 68 been implicated in this direct recognition of DENV-infected cells ( Conditioned supernatants from aforementioned DENV-infected primary monocyte cultures were 159 UV-inactivated as previously described. They were then used to culture primary monocytes from 160 the same donors from which the supernatants were collected. After a 24-hour incubation, 161 monocytes were stained with APC-conjugated anti-CD3, APC-conjugated anti-CD7, PE-162 conjugated anti-pan HLA class I, and Zombie Aqua Fixable Viability dye (BioLegend), then 163 analyzed using a Cytek TM Aurora analyzer and FlowJo Ⓡ 10.2. 164
Quantification of cytokine production by Luminex 165
The concentrations of cytokines in conditioned supernatants from the aforementioned DENV-166 infected primary monocyte cultures were assessed in duplicate using a multiplex cytokine assay 167 by Luminex per the manufacturer's instructions. 168
2.9 NK cell degranulation assay 169
Monocytes were infected with DENV-2 at an MOI of 2 and incubated for 24 hours. After 170 incubation, monocytes were left unblocked, blocked with an anti-pan human HLA class I Fab 171
(generated from DX17, BD Bioscience), with an anti-human HLA-E Fab (generated from 3D12, 172 BioLegend), or with isotype-matched control mouse IgG1 Fab (generated from 173 BioLegend) all at 7.3 μ g/mL for 30 minutes before adding autologous, IL-2-activated NK cells at 174 a 1:5 effector to target (E:T) ratio. Fabs were produced using mouse IgG1 Fab F(ab)2 Kits 175 (Thermo Scientific) and verified by gel electrophoresis and Coomassie Blue staining. During the 176 4-hour co-culture, cells were incubated with brefeldin A (eBioscience), monensin (eBioscience), 177
and APC-H7-conjugated anti-CD107a (H4A3, BD Bioscience) per manufacturer's instructions. 178
Cells were stained with PerCP-Cy5.5-conjugated anti-CD3, FITC-conjugated anti-CD7, Alexa 179
Fluor 700-conjugated anti-CD16 (3G8, BioLegend), PE-Cy7-conjugated anti-CD56 (HCD56,  180 BioLegend), and Zombie Aqua Fixable Viability dye, then analyzed using a Cytek TM Aurora 181 analyzer and FlowJo into clusters based on expression of key lineage markers; manual gating confirmed cluster 198 identity ( Figure 1A and Supplementary Figure 1A) . Analysis based on protein expression 199 revealed marked upregulation of total HLA class I and HLA-E in DENV-infected adults 200 compared to healthy controls across multiple immune cell subsets ( Figure 1B and 201 Supplementary Figure 1B) . As HLA-E can also be shed as soluble HLA-E (sHLA-E), which 202 has been implicated as a potential viral mechanism of NK cell evasion (Shwetank et al., 2013, 203 2014), we performed an sHLA-E ELISA. There was no significant difference in the 204 concentration of sHLA-E between the DENV-infected adults and healthy controls 205
( Supplementary Figure 2) . Together, these findings indicate that upregulation of HLA class I 206 occurs on the cell surface of multiple immune cell subsets during acute in vivo DENV infection. 207
Interestingly, viSNE visualization revealed that upregulation of total HLA class I and 208
HLA-E was not uniform across all monocytes. Instead, there were clear HLA class I high and 209
HLA-E high expressing monocytes. We gated on these cells ( Figure 1C to identify associated markers. The GLMM identified 10 markers (CD14, HLA-DR, HLA-E, 212
LFA-3, CCR2, CD95, CD48, ICAM-1, CD163, and Nectin-1) whose expression was associated 213
with HLA class I high monocytes ( Figure 1D ) and 5 markers (HLA class I, CD11b, ULBP-1,2,5,6, 214 CD163, and MICA/B) whose expression was associated with HLA-E high monocytes 215
(Supplementary Figure 3B) . We then verified these markers by comparing the expression level 216 of each marker in HLA high expressing monocytes to the expression level in HLA low expressing 217 monocytes from DENV-infected adults (Supplementary Figure 3C and Supplementary 218 Figure 4A ). Finally, we gated down to monocytes expressing all 10 or all 5 markers in DENV-219 infected adults (Supplementary Figure 3D and Supplementary Figure 4B) , and found that the 220 10 marker subset and the 5 marker subset expressed HLA class I and HLA-E, respectively, at 221 significantly higher levels than total monocytes from the same donor ( Figure 1E, Figure 1F , 222
Supplementary Figure 3E, and Supplementary Figure 3F ) verifying that combinatorial gating 223 using the aforementioned markers accurately identifies HLA class I high and HLA-E high 224 monocytes. Using the same gating scheme, we gated on the 10 and 5 marker monocyte subsets in 225 healthy controls and found that HLA class I expression by the 10 marker subset and HLA-E 226 expression by the 5 marker subset were both 1.6-fold higher in DENV-infected adults compared 227
to healthy controls ( Supplementary Figure 3G and Supplementary Figure 4C) . Figures 5A and 5B) . By 48 hpi, HLA class I expression was 2.1-fold higher in 237 monocytes infected with active DENV compared to mock (Figure 2A and 2B) . Interestingly, in 238 the active virus cultures, the uninfected bystander monocytes had a modest 1.1-and 1.2-fold 239
higher HLA class I expression at 24 ( Supplementary Figures 5C and 5D ) and 48 ( Figure 2C  240 and 2D) hpi, respectively, than infected monocytes in the same culture. This suggests HLA class 241 I upregulation is primarily restricted to infected cells with a modest impact on uninfected cells, 242 likely due to changes in the cytokine milieu. Alternatively, bystander cells in our assay may have 243 been infected at a level below our limit of detection. 244
Expression of HLA-E was also altered during DENV infection. At 24 and 48 hpi, 245 exposure to UV-inactivated DENV or infection with active DENV resulted in a majority of 246 monocytes becoming HLA-E high ( Supplementary Figure 5E and Figure 2E) . Similarly, at 48 247 hpi, the percentage of HLA-E high monocytes in the UVed and active DENV cultures was 2.8-and 248 3-fold higher, respectively, compared to mock-infected monocytes ( Figure 2F) . The increase of 249
HLA-E high monocytes was 3-fold for both virus conditions compared to mock at 24 hpi 250 ( Supplementary Figure 5F) . At both time points, bystander monocytes in the active DENV 251
cultures had a bimodal distribution of HLA-E low and HLA-E high cells, while infected cells were 252 all HLA-E high (Figure 2G and Supplementary Figure 5G) . Infected monocytes displayed a 1.3-253 fold increase in the percentage of HLA-E high monocytes at 24 hpi compared to bystander 254 monocytes (Supplementary Figure 5H) , but at 48 hpi there was no longer a significant 255 difference ( Figure 2H) . These results suggest that the response to viral proteins, rather than viral 256 replication, is the main driver of HLA-E upregulation. 257
Considering that bystander monocytes expressed higher levels of HLA class I than DENV-258 infected monocytes, we wanted to test whether secreted factors, such as cytokines, viral proteins, 259 and other molecules produced during active DENV infection were sufficient to upregulate HLA 260 class I. To this end, we UV-treated conditioned supernatants from previous 48-hour cultures of 261 primary monocytes that were mock-infected, exposed to UV-inactivated DENV, or infected with 262 active DENV. We then isolated uninfected monocytes from the same donors from which the 263 supernatants were collected and cultured them in the conditioned supernatants for 24 hours. 264
Supernatants collected from active, DENV-infected cultures led to a significant, if modest, 1.1-265 fold increase in HLA class I expression compared to monocytes cultured in supernatants 266 collected from the mock-infected and UV-inactivated DENV cultures ( Figure 3A and 3B) . This 267 increase in HLA class I expression shows that soluble factors secreted during active DENV 268 infection could be contributing to HLA class I upregulation. In order to investigate the potential 269 role of cytokines in mediating this increase in HLA class I expression, we used Luminex to 270 determine the concentration of cytokines present in the conditioned supernatants. We found that 271 the concentrations of IFN-α, IFN-β, and TNF-α were 759.2-, 26-, and 271.7-fold higher 272 respectively in the active condition compared to mock and 59.9-, 12.3-, and 2.8-fold higher 273 respectively in the active condition compared to the UVed condition ( Figure 3C) . These findings 274
suggest that upregulation of HLA class I during active DENV infection is largely driven by viral 275 replication, and is likely mediated to some extent by cytokines. It is important to note that viral 276 RNA, proteins, and particles present in the supernatant of active infection cultures could also 277 contribute to HLA class I upregulation. 278
Given that NK cell activation is dampened by the expression of self-HLA class I on 279
potential target cells, we investigated the impact of DENV-mediated HLA class I upregulation 280
on NK cell degranulation in response to DENV-infected cells. We co-cultured DENV-infected 281 primary monocytes with autologous primary NK cells in the presence of an isotype-matched 282
control Fab, an anti-pan HLA class I blocking Fab, or an anti-HLA-E blocking Fab for 4 hours 283
and measured the percentage of CD107a+ NK cells as a marker of degranulation and killing 284 activity ( Figure 4A and 4B) . Fabs were used instead of whole IgG to avoid killing via ADCC 285
following binding of the anti-HLA antibodies to the target cells. Blocking HLA class I on mock-286 infected monocytes led to a 9.7% frequency of CD107a+ NK cells, a 4.5% increase from 5.2% in 287 the unblocked, mock-infected monocyte condition. Because NK cells can become activated 288 when they are unable to bind self-HLA class I, this result demonstrates that the Fabs were 289 effectively blocking their targeted proteins. Blocking HLA class I on DENV-infected monocytes 290 resulted in nearly double the frequency of CD107a+ NK cells compared to DENV-infected 291 monocytes blocked with the isotype-matched control Fab, increasing from 9.9% to 18.8%. 292
Additionally, HLA class I-blocking of DENV-infected monocytes resulted in a 6.7% increase in 293 CD107a+ NK cells compared to blocking HLA-E. Blocking HLA class I on DENV-infected 294 monocytes also nearly doubled the frequency of CD107a+ NK cells compared to blocking HLA 295 class I on mock-infected cells, increasing from 9.7% to 18.8% (P = 0.0312). cell binding to  355  HLA class I using Fabs, we found HLA class I expression on DENV-infected cells significantly  356 dampens NK cell degranulation. This provides the first direct evidence that upregulation of HLA 357 class I is responsible for inhibition of NK cell responses to flavivirus-infected cells. We did 358 observe some non-specific increase in NK cell degranulation in the presence of the isotype-359 matched control antibody, but this effect was dwarfed by the increase in NK cell degranulation in 360 response to DENV-infected cells in the presence of HLA class I blocking Fabs. These findings 361
indicate that HLA class I expression dampens the magnitude of the NK cell response. 362
Previous studies using cytokine-activated endothelial cells showed that blocking surface 363
HLA-E and sHLA-E increased NK cell killing, illustrating the importance of HLA-E expression 364 as a potential NK escape mechanism in some vascular diseases (Coupel et al., 2007 infection. Primary monocytes isolated from whole PBMCs from healthy blood bank donors were 567 mock-infected (blue), exposed to UV-inactivated DENV (orange), or infected with active DENV 568 (red) for 48 hours. Representative histograms of HLA class I (A) and HLA-E (E) expression in 569 total monocytes cultured in the respective conditions. Fluorescence minus one (FMO) shown in 570 grey. HLA class I MFI in total monocytes (B) as well as bystander (DENV-) and infected 571 (DENV+) monocytes (D). Representative histograms of HLA class I (C) and HLA-E (G) 572 expression in bystander monocytes (DENV-, green) and infected monocytes (DENV+, purple). 573
Percentage of HLA-E high total monocytes (F) as well as bystander and infected monocytes (H). 574
Two independent experiments measuring HLA class I were performed with 6 donors. The 575 average for each donor is represented in the graphs. n = 12 for HLA-E experiments. Friedman 576 test followed by Dunn's multiple comparisons test was used to analyze total monocytes. 577
Wilcoxon signed-rank test was used to analyze DENV-vs. DENV+ monocytes. *P < 0.05, **P 578 < 0.01, ***P < 0.0001. 579 
